Nutra ProVital MMN

Nutrition support in cancer patients aims to maintain or improve nutrient intake, mitigate metabolic derangements, maintain skeletal muscle mass and physical performance, decrease the risk of reductions or interruptions of scheduled anticancer treatments, and improve quality of life.

Carnosine has been shown to inhibit the proliferation of human gastric carcinoma cells by regulating Akt and mammalian target of rapamycin (mTOR) signalling.

Omega-3 PUFAs play essential roles in cell signaling and, in the cell, structure and fluidity of membranes. Cancer-related complications like anorexia-cachexia syndrome, pain, depression, and paraneoplastic syndromes could potentially be managed by omega-3 PUFA supplementation.

Taurine can significantly improve chemotherapy-induced taste and smell alterations.

Glutamine is a major dietary amino acid that is both a fuel and nitrogen donor for healing tissues damaged by chemotherapy and radiation. Benefits include not only better nutrition, but also decreased mucosal damage (mucositis, stomatitis, pharyngitis, esophagitis, and enteritis).

Arginine is an amino acid critically involved in multiple cellular processes including the synthesis of nitric oxide and polyamines, and is a direct activator of mTOR, a nutrient-sensing kinase strongly implicated in carcinogenesis.

Micronutrient deficiencies have, basically, a negative effect on the course of malignant disease and the efficiency of treatment intended to destroy tumors, as it impairs immunocompetence, increases the risk of complications, and impacts on the patient’s physical and mental quality of life.

Besides aiming at compensating the micronutrient deficit caused by the tumor disease, MMN supplements can also influence the course of the disease in a beneficial way: i) to support wound healing; ii) to counteract tumor cachexia; and iii) in the longer term to improve the patient’s quality of life and prognosis.